Biology Reference
In-Depth Information
[153] Weng L, Dyson J, Dazzi F. Low-intensity transplant regimens facilitate recruitment of
donor-specific regulatory T cells that promote hematopoietic engraftment. Proc Natl
Acad Sci USA 2007;104:8415-20.
[154] Bayer AL, Jones M, Chirinos J, de Armas L, Schreiber TH, Malek TR, et al. Host
CD4
+
CD25
+
T cells can expand and comprise a major component of the Treg compart-
ment after experimental HCT. Blood 2009;113:733-43.
[155] Boyman O, Kovar M, Rubinstein MP, Surh CD, Sprent J. Selective stimulation of T cell
subsets with antibody-cytokine immune complexes. Science 2006;311:1924-7.
[156] Wing K, Onishi Y, Prieto-Martin P, Yamaguchi T, Miyara M, Fehervari Z, et al. CTLA-4
control over Foxp3
+
regulatory T cell function. Science 2008;322:271-5.
[157] Tawara I, Shlomchik WD, Jones A, Zou W, Nieves E, Liu C, et al. A crucial role for host
APCs in the induction of donor CD4
+
CD25
+
regulatory T cell-mediated suppression of
experimental graft-versus-host disease. J Immunol 2010;185:3866-72.
[158] Lu LF, Lind EF, Gondek DC, Bennett KA, Gleeson MW, Pino-Lagos K, et al. Mast cells
are essential intermediaries in regulatory T-cell tolerance. Nature 2006;442:997-1002.
[159] Shevach EM. Mechanisms of foxp3
+
T regulatory cell-mediated suppression. Immunity
2009;30:636-45.
[160] Sandmaier BM, Storb R. Reduced-intensity conditioning followed by hematopoietic
cell transplantation for hematologic malignancies. Thomas' Hematopoietic Cell Trans-
plantation. Oxford: Wiley-Blackwell; 2009. pp. 1043-58.
[161] Luznik L, Jalla S, Engstrom LW, Iannone R, Fuchs EJ. Durable engraftment of major
histocompatibility complex-incompatible cells after nonmyeloablative conditioning
with fludarabine, low-dose total body irradiation, and posttransplantation cyclophos-
phamide. Blood 2001;98:3456-64.
[162] Luznik L, Jones RJ, Fuchs EJ. High-dose cyclophosphamide for graft-versus-host dis-
ease prevention. Curr Opin Hematol 2010;17:493-9.
122
Search WWH ::
Custom Search